CDK5-USP30信号通路通过抑制MPTP/MPP+ PD模型中的线粒代谢来调节MAVS介导的炎症
Yixian Ren1, Xian Wu2, Tianyao Bai2
1Department of Occupational Health and Occupational Medicine, Guangdong Province Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong Province, China; Key Laboratory of Occupational Environment and Health, Guangzhou Occupational Disease Prevention and Treatment Hospital, Guangzhou, China.
Ecotoxicology and environmental safety
|May 21, 2024
概括
像MPTP这样的环境污染物可以导致帕金森病 (PD). 这项研究揭示了CDK5-USP30-MAVS通路阻断线粒并促进炎症,为PD提供了一个新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- 环境污染物,如MPTP,与帕金森病 (PD) 病原发生有关.
- 由MPTP诱导的神经毒性涉及线粒体功能障碍和神经炎症,但确切的机制尚不清楚.
研究的目的:
- 为了阐明CDK5-USP30-MAVS在MPTP/MPP+诱导的帕金森病中的新信号机制.
- 为了研究 mitophagy 和炎症在MPTP神经毒性的作用.
主要方法:
- 使用了BV2微质细胞和MPTP小鼠模型.
- 研究了MPP+治疗,菌体刺激 (Urolithin A),USP30淘汰和CDK5抑制的作用.
- 分析了蛋白质水平,线粒细胞衰老,线粒体功能和炎症标志物.
主要成果:
- MPP+增加了USP30,抑制了线粒体,损害了线粒体功能,并诱导了MAVS介导的炎症.
- 线粒刺激和USP30敲击改善了MPP+诱导的炎症.
- CDK5激活稳定了USP30,促进了MAVS介导的炎症.
- CDK5抑制保护免受MPTP/MPP+诱导的神经退行和运动缺陷.
结论:
- CDK5-USP30-MAVS通路是MPTP/MPP+诱导的帕金森病的关键调解者.
- 通过USP30酸化,CDK5阻断了线粒,激活了MAVS驱动的炎症.
- 针对CDK5-USP30-MAVS通路提供了与环境神经毒性污染物相关的PD的潜在治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


